User:MichaelLau0117/sandbox

Anbio Biotechnology Incorporated
Anbio Biotechnology is a medical device company emphasizing in vitro diagnostics. Its mission is to change the diagnostics industry by individualizing and decentralizing the current diagnostic solutions for rapid diagnosis to improve patient prognosis. They propose to provide rapid, accessible, and affordable diagnostic solutions at the forefront of science and offer innovative laboratory and point of care (POCT) in vitro diagnostic (IVD) products.

History
Incorporated under the laws of the Cayman Islands, Anbio Biotechnology has a portfolio of laboratory diagnostics and point-of-care technology (POCT) products that range from infectious diseases to cancer, cardio, and diabetes detection.

Products and Solutions
Chemiluminescence Immunoassay Instrument and Reagents Anbio Scientist-500 is a high throughput turnkey immunoassay solution with a small footprint. The Anbio Scientist-500 comes with a multitude of testing, including cancer, inflammation, hormone levels, diabetes, and cardiovascular. With the Anbio Scientist-500, laboratories can provide over 49 disease screening tests in a high-throughput and reliable manner. The Anbio Scientist-500 instrument and assays are registered for commercialization in the EU and suitable for the LDT space in the US.

Fluorescence Immunochromatographic Assay (FIA) Instrument and Reagents - The Anbio 100s FIA reader and immunoassays solution is a point of care solution for rapid mobile disease screening. Small in footprint (195x100x70mm) and mobile, the Anbio 100s solution is designed for use in private healthcare clinics, urgent cares, emergency rooms, and ambulances. Forty-eight (48) different disease screening tests are available for the Anbio 100s FIA solution including cancer, inflammation, hormone levels, diabetes, and cardiovascular. Anbio 100s FIA instrument and assays are registered for commercialization in the EU and designed for the LDT space in the US.

Anbio Lateral Flow Assays (Colloidal Gold) - Anbio Biotechnology has 43 different Lateral Flow Assays (Colloidal Gold) registered for commercialization in the EU that screens for infectious diseases, drug abuse, cancers, cardiac disorder, and hormonal disorders. The Anbio Lateral Flow Assays (Colloidal Gold) are designed to be without the need for expensive, complex laboratories. This allows for rapid identification of disease related biomarkers.

Molecular Assays (RT-PCR and LAMP) - Anbio Biotechnology have 12 molecular diagnostic assays registered for commercialization in the EU and suitable to be validated as a laboratory-developed diagnostic test in the US. The Anbio molecular diagnostic assays (RT-PCR and LAMP) can screen for biomarkers for infectious, cardiac, and other genetic diseases. One example is the Anbio Infectious Diseases LAMP Test Kit that is a reverse transcription loop-mediated isothermal amplification-based test kit for rapid identification of infection.

External links section
http://www.anbio.com